NZ723841A - New compositions for treating amyotrophic lateral sclerosis - Google Patents
New compositions for treating amyotrophic lateral sclerosisInfo
- Publication number
- NZ723841A NZ723841A NZ723841A NZ72384113A NZ723841A NZ 723841 A NZ723841 A NZ 723841A NZ 723841 A NZ723841 A NZ 723841A NZ 72384113 A NZ72384113 A NZ 72384113A NZ 723841 A NZ723841 A NZ 723841A
- Authority
- NZ
- New Zealand
- Prior art keywords
- lateral sclerosis
- amyotrophic lateral
- treating amyotrophic
- new compositions
- relates
- Prior art date
Links
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 2
- KPYSYYIEGFHWSV-UHFFFAOYSA-N Baclofen Chemical compound OC(=O)CC(CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-UHFFFAOYSA-N 0.000 abstract 2
- AFCGFAGUEYAMAO-UHFFFAOYSA-N acamprosate Chemical compound CC(=O)NCCCS(O)(=O)=O AFCGFAGUEYAMAO-UHFFFAOYSA-N 0.000 abstract 2
- 229960004047 acamprosate Drugs 0.000 abstract 2
- 229960000794 baclofen Drugs 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 abstract 1
- NGBFQHCMQULJNZ-UHFFFAOYSA-N Torsemide Chemical compound CC(C)NC(=O)NS(=O)(=O)C1=CN=CC=C1NC1=CC=CC(C)=C1 NGBFQHCMQULJNZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960004181 riluzole Drugs 0.000 abstract 1
- 229960005461 torasemide Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to compositions and methods for the treatment of amyotrophic lateral sclerosis (ALS). More specifically, the present invention relates to novel combinatorial therapies comprising acamprosate and baclofen for treating amyotrophic lateral sclerosis or a related disorder. The present invention also relates to novel combinatorial therapies comprising acamprosate and baclofen in combination with torasemide and/or riluzole for treating amyotrophic lateral sclerosis or a related disorder
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2012/053570 WO2012117076A2 (en) | 2011-03-01 | 2012-03-01 | Baclofen and acamprosate based therapy of neurogical disorders |
| PCT/EP2012/053565 WO2012117073A2 (en) | 2011-03-01 | 2012-03-01 | New compositions for treating neurological disorders |
| NZ70017513 | 2013-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ723841A true NZ723841A (en) | 2018-02-23 |
Family
ID=61226336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ723841A NZ723841A (en) | 2012-03-01 | 2013-02-28 | New compositions for treating amyotrophic lateral sclerosis |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ723841A (en) |
-
2013
- 2013-02-28 NZ NZ723841A patent/NZ723841A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019011905A (en) | New compositions for treating amyotrophic lateral sclerosis. | |
| MX356525B (en) | Aav -vectors for use in gene therapy of choroideremia. | |
| IN2014DN05986A (en) | ||
| MX2019001977A (en) | Methods and compositions for treating multiple sclerosis and related disorders. | |
| UA114090C2 (en) | Metalloenzyme inhibitor compounds | |
| IN2015DN00438A (en) | ||
| IN2014DN06792A (en) | ||
| MY191932A (en) | Chitosan-derived compositions | |
| IN2014CN04014A (en) | ||
| MX343931B (en) | Treatment of amyotrophic lateral sclerosis using umbilical derived cells. | |
| PH12016500903A1 (en) | Novel methods for treating neurodegenerative diseases | |
| MX2015006337A (en) | Methods and compositions for treating neurodegenerative diseases. | |
| TN2013000388A1 (en) | Anticoagulant antidotes | |
| EP4023243A3 (en) | Compositions and methods for treating celiac sprue disease | |
| MX2014010940A (en) | The use of antithrombin in the treatment of pre-eclampsia. | |
| IN2014DN00254A (en) | ||
| MX2013014488A (en) | Methods and compositions for treating brain cancer. | |
| WO2013163562A3 (en) | Compositions and methods for treating ptsd and related diseases | |
| MX2013002111A (en) | Methods and compositions for treating cancer metastasis. | |
| IN2015DN00820A (en) | ||
| IN2014DN07989A (en) | ||
| NZ723841A (en) | New compositions for treating amyotrophic lateral sclerosis | |
| IN2014KN02952A (en) | ||
| MX2014006990A (en) | Treatment of type i and type ii diabetes. | |
| UA114811C2 (en) | New compositions for treating amyotrophic lateral sclerosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 FEB 2020 BY JAMES + WELLS Effective date: 20190208 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 FEB 2021 BY IPAN GMBH Effective date: 20200224 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 FEB 2022 BY IPAN GMBH Effective date: 20210208 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 FEB 2023 BY IPAN GMBH Effective date: 20220207 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 FEB 2024 BY IPAN GMBH Effective date: 20230228 |
|
| LAPS | Patent lapsed |